EUVIMEDEUVIMED entdecken
Crossref

Delayed diagnosis of early-onset N-acetylglutamate synthase deficiency in two related Saudi children

Mai Labani, Talal ALAnzi, Moeenaldeen AlSayed, Anwar Almughyiri

Journal of Biochemical and Clinical Genetics · 2026

DOI: 10.24911/jbcgenetics.11-2782 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Clinical Genetics, 2026. Verfasst von Mai Labani und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

N-acetylglutamate synthase deficiency (NAGSD) is the rarest urea cycle disorder and a potentially treatable cause of neonatal hyperammonemia. Because it may not be detected by routine newborn screening, delayed diagnosis can result in irreversible neurological injury.

Objective

To describe the clinical, biochemical, and molecular findings of two related patients with NAGSD and to highlight the importance of early recognition and treatment.

Methods

We report two related patients with clinically and molecularly confirmed NAGSD. Clinical presentation, biochemical results, neuroimaging, genetic findings, and treatment outcomes were reviewed.

Results

Both patients presented in the neonatal period with hyperammonemia and later developed recurrent metabolic decompensation and seizures. Biochemical evaluation showed elevated glutamine with normal citrulline and normal acylcarnitine profiles, making early biochemical recognition challenging. Whole exome sequencing identified a homozygous pathogenic splice-site variant in the NAGS gene, c.427-2A>T, in both patients. Despite treatment with carglumic acid and dietary management, both developed significant neurodevelopmental delay, likely secondary to early hyperammonemic brain injury. Neuroimaging findings were consistent with metabolic encephalopathy. After diagnosis and treatment, no further hyperammonemic crises were reported.

Conclusion

NAGSD should be considered in any neonate with unexplained hyperammonemia, even when newborn screening and citrulline levels are normal. Early empirical treatment with carglumic acid may be life-saving and can reduce the risk of permanent neurological damage, especially in high-consanguinity populations.

Zitieren

APA

Labani, M., ALAnzi, T., AlSayed, M., & Almughyiri, A. (2026). Delayed diagnosis of early-onset N-acetylglutamate synthase deficiency in two related Saudi children. Journal of Biochemical and Clinical Genetics. https://doi.org/10.24911/jbcgenetics.11-2782

Vancouver

Labani M, ALAnzi T, AlSayed M, Almughyiri A. Delayed diagnosis of early-onset N-acetylglutamate synthase deficiency in two related Saudi children. Journal of Biochemical and Clinical Genetics. 2026. doi:10.24911/jbcgenetics.11-2782

BibTeX
@article{Labani2026,
  author = {Labani, Mai and ALAnzi, Talal and AlSayed, Moeenaldeen and Almughyiri, Anwar},
  title = {Delayed diagnosis of early-onset N-acetylglutamate synthase deficiency in two related Saudi children},
  journal = {Journal of Biochemical and Clinical Genetics},
  year = {2026},
  doi = {10.24911/jbcgenetics.11-2782}
}
Kostenlos starten →